Author:
Kärner Anita,Nilsson Staffan,Jaarsma Tiny,Andersson Agneta,Wiréhn Ann-Britt,Wodlin Peter,Hjelmfors Lisa,Tingström Pia
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori S, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte Op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano J: European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007, 28: 2375-2414.
2. The National Board of Health and Welfare: Myocardial infarctions 1987–2007. Official statistics of Sweden - Statistics - Health and Medical Care. 2009, Stockholm,
http://www.socialstyrelsen.se/publikationer2009/2009-12-7
.
3. Simpson CR, Buckley BS, McLernon DJ, Sheikh A, Murphy A, Hannaford PC: Five-year Prognosis in an Incident Cohort of People Presenting with Acute Myocardial Infarction. PLoS One. 2011, 6 (10): e26573-10.1371/journal.pone.0026573.
4. De Backer G: New European guidelines for cardiovascular disease prevention in clinical practice. Clin Chem Lab Med. 2009, 47 (2): 138-142.
5. Everly M, Heaton P, Cluxton RJ: Beta-blocker underuse in secondary prevention of myocardial infarction. Ann Pharmacother. 2004, 38 (2): 286-293.